Remove Diagnose Remove Disease Remove Events Remove Hospital
article thumbnail

Beware risk of adverse events associated with GBCAs

AuntMinnie

To make the situation more complicated, not all possible adverse events from GBCAs are noted in drug packaging, wrote a team led by Lu Wang , PhD, of Yantai Yuhuangding Hospital in Yantai, China. Adverse events occurred more frequently among women across all four drugs. Extra studies are needed to enhance the safety of GBCAs."

Education 105
article thumbnail

GE HealthCare Signs $44 Million Contract with BARDA to Develop Artificial Intelligence-Augmented Ultrasound Technology to Aid Clinicians in Diagnosing and Treating Traumatic Injury and Enhance National Preparedness for Mass Casualty Incidents

Imaging Technology

Technology resulting from this jointly funded program will help healthcare professionals at all skill levels rapidly diagnose and provide timely treatment for patients with lung pathologies and traumatic injuries to the abdomen, chest and head. Trauma patients’ survival is dependent on receiving timely and appropriate care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study: Ditch the contrast agent in PET/MRI scans in children with lymphoma

AuntMinnie

In a scientific session held November 30, Nils-Martin Bruckmann, MD, of University Hospital DĂĽsseldorf in Germany, discussed a study that evaluated FDG-PET/MRI scans with and without the use of a contrast agent in children with newly diagnosed disease. The study authors found the contrast agent made no diagnostic difference.

MRI 111
article thumbnail

GE HealthCare Receives FDA Clearance of a New Deep Learning Solution for Enhanced Image Quality in PET/CT, Advancing its Leadership Position in AI

Imaging Technology

We can’t treat what we don’t see, which is why we require precise image quality to help diagnose, plan treatment for, and monitor disease,” explains Prof. Medical imaging is a crucial tool for diagnosing disease, identifying a course of treatment, and determining whether therapy is successful for millions of patients around the world.

article thumbnail

Breast Cancer Awareness Month Kicks Off Now: The Latest in Breast Cancer Studies

Vesta Teleradiology

October is Breast Cancer Awareness Month, a time when individuals and organizations around the world unite to raise awareness about one of the most prevalent and potentially life-threatening diseases affecting women and, in some cases, men. Migraine and Breast Cancer: Is There a Link? Are Older Women At Risk for Overdiagnosis?

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman. It's full-spectrum, personalized care," Vroman told AuntMinnie.com.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman. It's full-spectrum, personalized care," Vroman told AuntMinnie.com.